Cardiovascular autonomic dysfunction in ""Long COVID"": pathophysiology, heart rate variability, and inflammatory markers

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorMARQUES, Karina Carvalho
dc.contributor.authorQUARESMA, Juarez Antonio Simoes
dc.contributor.authorFALCAO, Luiz Fabio Magno
dc.date.accessioned2024-04-05T19:36:29Z
dc.date.available2024-04-05T19:36:29Z
dc.date.issued2023
dc.description.abstractLong COVID is characterized by persistent signs and symptoms that continue or develop for more than 4 weeks after acute COVID-19 infection. Patients with Long COVID experience a cardiovascular autonomic imbalance known as dysautonomia. However, the underlying autonomic pathophysiological mechanisms behind this remain unclear. Current hypotheses include neurotropism, cytokine storms, and inflammatory persistence. Certain immunological factors indicate autoimmune dysfunction, which can be used to identify patients at a higher risk of Long COVID. Heart rate variability can indicate autonomic imbalances in individuals suffering from Long COVID, and measurement is a non-invasive and low-cost method for assessing cardiovascular autonomic modulation. Additionally, biochemical inflammatory markers are used for diagnosing and monitoring Long COVID. These inflammatory markers can be used to improve the understanding of the mechanisms driving the inflammatory response and its effects on the sympathetic and parasympathetic pathways of the autonomic nervous system. Autonomic imbalances in patients with Long COVID may result in lower heart rate variability, impaired vagal activity, and substantial sympathovagal imbalance. New research on this subject must be encouraged to enhance the understanding of the long-term risks that cardiovascular autonomic imbalances can cause in individuals with Long COVID.eng
dc.description.indexPubMed
dc.description.indexScopus
dc.description.indexDimensions
dc.description.indexWoS
dc.description.sponsorshipAmazon Foundation for Research Support (FAPESPA) [001]
dc.description.sponsorshipProfessional, and Technological Education (SECTET) [13/2020, 406360/2022-7]
dc.description.sponsorshipHigher Education Personnel Improvement Coordination-Brazil (CAPES)
dc.description.sponsorshipNational Council for Scientific and Technological Development-Brazil
dc.description.sponsorship[006/2020]
dc.identifier.citationFRONTIERS IN CARDIOVASCULAR MEDICINE, v.10, article ID 1256512, 11p, 2023
dc.identifier.doi10.3389/fcvm.2023.1256512
dc.identifier.issn2297-055X
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/59098
dc.language.isoeng
dc.publisherFRONTIERS MEDIA SAeng
dc.relation.ispartofFrontiers in Cardiovascular Medicine
dc.rightsopenAccesseng
dc.rights.holderCopyright FRONTIERS MEDIA SAeng
dc.subjectLong COVIDeng
dc.subjectautonomic nervous systemeng
dc.subjectautonomic diseaseseng
dc.subjectpathophysiologyeng
dc.subjectinflammationeng
dc.subjectheart rate variabilityeng
dc.subject.othersympathetic activityeng
dc.subject.othernervous-systemeng
dc.subject.otherneuroinflammationeng
dc.subject.otherbiomarkerseng
dc.subject.otherinfectioneng
dc.subject.otherfailureeng
dc.subject.otherhealthyeng
dc.subject.otherimpacteng
dc.subject.wosCardiac & Cardiovascular Systemseng
dc.titleCardiovascular autonomic dysfunction in ""Long COVID"": pathophysiology, heart rate variability, and inflammatory markerseng
dc.typearticleeng
dc.type.categoryrevieweng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.author.externalMARQUES, Karina Carvalho:State Univ Para UEPA, Ctr Biol & Hlth Sci, Belem, Para, Brazil
hcfmusp.citation.scopus5
hcfmusp.contributor.author-fmusphcJUAREZ ANTONIO SIMOES QUARESMA
hcfmusp.contributor.author-fmusphcLUIZ FABIO MAGNO FALCAO
hcfmusp.description.articlenumber1256512
hcfmusp.description.volume10
hcfmusp.origemWOS
hcfmusp.origem.dimensionspub.1163755186
hcfmusp.origem.pubmed37719983
hcfmusp.origem.scopus2-s2.0-85171335552
hcfmusp.origem.wosWOS:001066158900001
hcfmusp.publisher.cityLAUSANNEeng
hcfmusp.publisher.countrySWITZERLANDeng
hcfmusp.relation.referenceAcanfora D, 2022, VIRUSES-BASEL, V14, DOI 10.3390/v14051035eng
hcfmusp.relation.referenceAcosta-Ampudia Y, 2022, J INFECT DIS, V225, P2155, DOI 10.1093/infdis/jiac017eng
hcfmusp.relation.referenceAeschbacher S, 2017, ANN MED, V49, P32, DOI 10.1080/07853890.2016.1226512eng
hcfmusp.relation.referenceAguglia A, 2022, LIFE-BASEL, V12, DOI 10.3390/life12101557eng
hcfmusp.relation.referenceAkanchise T, 2023, ANTIOXIDANTS-BASEL, V12, DOI 10.3390/antiox12020393eng
hcfmusp.relation.referenceAlen NV, 2022, NEUROSCI BIOBEHAV R, V136, DOI 10.1016/j.neubiorev.2022.104622eng
hcfmusp.relation.referenceAlen NV, 2021, BRAIN BEHAV IMMUN-HL, V15, DOI 10.1016/j.bbih.2021.100273eng
hcfmusp.relation.referenceAllendes FJ, 2023, FRONT MED-LAUSANNE, V9, DOI 10.3389/fmed.2022.1095249eng
hcfmusp.relation.referenceAmruta N, 2021, CYTOKINE GROWTH F R, V58, P1, DOI 10.1016/j.cytogfr.2021.02.002eng
hcfmusp.relation.referenceArakaki X, 2023, FRONT NEUROSCI-SWITZ, V17, DOI 10.3389/fnins.2023.1055445eng
hcfmusp.relation.referenceAsarcikli LD, 2022, J INTERV CARD ELECTR, V63, P715, DOI 10.1007/s10840-022-01138-8eng
hcfmusp.relation.referenceBarizien N, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-93546-5eng
hcfmusp.relation.referenceBecker RC, 2021, J THROMB THROMBOLYS, V52, P692, DOI 10.1007/s11239-021-02549-6eng
hcfmusp.relation.referenceBisaccia G, 2021, J CARDIOVASC DEV DIS, V8, DOI 10.3390/jcdd8110156eng
hcfmusp.relation.referenceBonaz B, 2016, NEUROGASTROENT MOTIL, V28, P455, DOI 10.1111/nmo.12817eng
hcfmusp.relation.referenceBonilla H, 2023, FRONT IMMUNOL, V14, DOI 10.3389/fimmu.2023.1129459eng
hcfmusp.relation.referenceBosco J, 2022, BMC INFECT DIS, V22, DOI 10.1186/s12879-022-07181-0eng
hcfmusp.relation.referenceBouayed MZ, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.1040024eng
hcfmusp.relation.referenceStella AB, 2022, J NEUROL, V269, P587, DOI 10.1007/s00415-021-10735-yeng
hcfmusp.relation.referenceCalabrese C, 2022, BEST PRACT RES CL RH, V36, DOI 10.1016/j.berh.2022.101794eng
hcfmusp.relation.referenceCamm AJ, 1996, CIRCULATION, V93, P1043eng
hcfmusp.relation.referenceCardinali DP, 2022, BIOMOLECULES, V12, DOI 10.3390/biom12111646eng
hcfmusp.relation.referenceChadda KR, 2022, FRONT CARDIOVASC MED, V9, DOI 10.3389/fcvm.2022.860198eng
hcfmusp.relation.referenceChakraborty A, 2023, PEDIATR CARDIOL, V44, P367, DOI 10.1007/s00246-022-03020-weng
hcfmusp.relation.referenceCooper TM, 2015, BRAIN BEHAV IMMUN, V49, P94, DOI 10.1016/j.bbi.2014.12.017eng
hcfmusp.relation.referenceCorrado J, 2022, BMJ OPEN, V12, DOI 10.1136/bmjopen-2022-066044eng
hcfmusp.relation.referenceCygankiewicz Iwona, 2013, Handb Clin Neurol, V117, P379, DOI 10.1016/B978-0-444-53491-0.00031-6eng
hcfmusp.relation.referenceDani M, 2021, CLIN MED, V21, pE63, DOI 10.7861/clinmed.2020-0896eng
hcfmusp.relation.referenceDe Maria Beatrice, 2021, Herzschrittmacherther Elektrophysiol, V32, P315, DOI 10.1007/s00399-021-00780-5eng
hcfmusp.relation.referenceDelevatti RS, 2023, TRIALS, V24, DOI 10.1186/s13063-022-07055-5eng
hcfmusp.relation.referenceDotan A, 2022, AUTOIMMUN REV, V21, DOI 10.1016/j.autrev.2022.103071eng
hcfmusp.relation.referenceEldokla AM, 2022, ANN CLIN TRANSL NEUR, V9, P778, DOI 10.1002/acn3.51557eng
hcfmusp.relation.referenceChrestia JF, 2022, MOL NEUROBIOL, V59, P6076, DOI 10.1007/s12035-022-02947-8eng
hcfmusp.relation.referenceFaust O, 2022, COMPUT BIOL MED, V145, DOI 10.1016/j.compbiomed.2022.105407eng
hcfmusp.relation.referenceFrasch MG, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.930445eng
hcfmusp.relation.referenceFreire Ana Paula Coelho Figueira, 2023, Int J Environ Res Public Health, V20, DOI 10.3390/ijerph20032251eng
hcfmusp.relation.referenceFreire APCF, 2022, INT J ENV RES PUB HE, V19, DOI 10.3390/ijerph19042457eng
hcfmusp.relation.referenceGalán M, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.848886eng
hcfmusp.relation.referenceGaris G, 2023, NEUROL SCI, V44, P83, DOI 10.1007/s10072-022-06385-1eng
hcfmusp.relation.referenceGlynne P, 2022, J INVEST MED, V70, P61, DOI 10.1136/jim-2021-002051eng
hcfmusp.relation.referenceGoldberger JJ, 2019, J AM COLL CARDIOL, V73, P1189, DOI 10.1016/j.jacc.2018.12.064eng
hcfmusp.relation.referenceGorog DA, 2022, NAT REV CARDIOL, V19, P475, DOI 10.1038/s41569-021-00665-7eng
hcfmusp.relation.referenceHaensel A, 2008, PSYCHONEUROENDOCRINO, V33, P1305, DOI 10.1016/j.psyneuen.2008.08.007eng
hcfmusp.relation.referenceHajiasgharzadeh Khalil, 2022, Clin Exp Neuroimmunol, DOI 10.1111/cen3.12703eng
hcfmusp.relation.referenceHasty F, 2021, MIL MED, V186, pE34, DOI 10.1093/milmed/usaa405eng
hcfmusp.relation.referenceHottenrott L, 2021, FRONT SPORTS ACT LIV, V3, DOI 10.3389/fspor.2021.612782eng
hcfmusp.relation.referenceHovaguimian A, 2023, NEUROL CLIN, V41, P193, DOI 10.1016/j.ncl.2022.08.002eng
hcfmusp.relation.referenceHugon J, 2022, J NEUROL, V269, P44, DOI 10.1007/s00415-021-10655-xeng
hcfmusp.relation.referenceJänig W, 2014, AUTON NEUROSCI-BASIC, V182, P4, DOI 10.1016/j.autneu.2014.01.004eng
hcfmusp.relation.referenceJammoul M, 2023, AUTON NEUROSCI-BASIC, V245, DOI 10.1016/j.autneu.2022.103071eng
hcfmusp.relation.referenceJing HJ, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.992384eng
hcfmusp.relation.referenceJohansson Madeleine, 2021, JACC Case Rep, V3, P573, DOI 10.1016/j.jaccas.2021.01.009eng
hcfmusp.relation.referenceJung I, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.752944eng
hcfmusp.relation.referenceKarakayali Muammer, 2023, Cureus, V15, pe40256, DOI 10.7759/cureus.40256eng
hcfmusp.relation.referenceKoc HC, 2022, INT J BIOL SCI, V18, P4768, DOI 10.7150/ijbs.75056eng
hcfmusp.relation.referenceKrantz MJ, 2006, ARCH INTERN MED, V166, P247, DOI 10.1001/archinte.166.2.247-aeng
hcfmusp.relation.referenceKurtoglu E, 2022, ANN NONINVAS ELECTRO, V27, DOI 10.1111/anec.12916eng
hcfmusp.relation.referenceKurul S, 2022, EUR J PEDIATR, V181, P3331, DOI 10.1007/s00431-022-04534-4eng
hcfmusp.relation.referenceLa Rovere MT, 2003, CIRCULATION, V107, P565, DOI 10.1161/01.CIR.0000047275.25795.17eng
hcfmusp.relation.referenceLagoumintzis G, 2021, FOOD CHEM TOXICOL, V149, DOI 10.1016/j.fct.2021.112009eng
hcfmusp.relation.referenceLampsas S., 2022, Eur Heart J, V43, pehac544.402, DOI [10.1093/eurheartj/ehac544.402, DOI 10.1093/EURHEARTJ/EHAC544.402]eng
hcfmusp.relation.referenceLarsen NW, 2022, FRONT NEUROL, V13, DOI 10.3389/fneur.2022.1012668eng
hcfmusp.relation.referenceLegramante JM, 2001, CIRCULATION, V103, P1250eng
hcfmusp.relation.referenceLionte C, 2022, DIAGNOSTICS, V12, DOI 10.3390/diagnostics12061373eng
hcfmusp.relation.referenceLiviero F, 2023, INT J ENV RES PUB HE, V20, DOI 10.3390/ijerph20010830eng
hcfmusp.relation.referenceMalkova AM, 2023, AUTOIMMUN REV, V22, DOI [10.1016/j.autrev.2022.103230, 10.1016/j.autrev.2022.103231]eng
hcfmusp.relation.referenceMaltezou HC, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9050497eng
hcfmusp.relation.referenceMarques KC, 2022, FRONT CARDIOVASC MED, V9, DOI 10.3389/fcvm.2022.862001eng
hcfmusp.relation.referenceMenezes AD Jr, 2023, J CLIN MED, V12, DOI 10.3390/jcm12010100eng
hcfmusp.relation.referenceO'Brien BCV, 2023, J BIOL CHEM, V299, DOI 10.1016/j.jbc.2023.104707eng
hcfmusp.relation.referenceOpsteen S, 2023, J INVEST MED, V71, P545, DOI 10.1177/10815589231158041eng
hcfmusp.relation.referencePan YC, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.630038eng
hcfmusp.relation.referencePapaioannou VE, 2013, CURR CARDIOL REV, V9, P82, DOI 10.2174/1573403X11309010010eng
hcfmusp.relation.referencePasini E, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.714426eng
hcfmusp.relation.referencePavlov VA, 2018, ANNU REV IMMUNOL, V36, P783, DOI 10.1146/annurev-immunol-042617-053158eng
hcfmusp.relation.referencePerumal R, 2023, FRONT IMMUNOL, V14, DOI 10.3389/fimmu.2023.1117464eng
hcfmusp.relation.referencePhetsouphanh C, 2022, NAT IMMUNOL, V23, P210, DOI 10.1038/s41590-021-01113-xeng
hcfmusp.relation.referenceRaj SR, 2021, CLIN AUTON RES, V31, P365, DOI 10.1007/s10286-021-00798-2eng
hcfmusp.relation.referenceRaman B, 2022, EUR HEART J, V43, P1157, DOI [10.1093/eurheartj/ehac031, 10.1093/eurheart/ehac031]eng
hcfmusp.relation.referenceRaveendran AV, 2021, DIABETES METAB SYND, V15, P869, DOI 10.1016/j.dsx.2021.04.007eng
hcfmusp.relation.referenceSabanoglu C, 2022, EUR REV MED PHARMACO, V26, P6396, DOI 10.26355/eurrev_202209_29667eng
hcfmusp.relation.referenceSchneider M, 2020, PSYCHOL MED, V50, P1937, DOI 10.1017/S003329172000207Xeng
hcfmusp.relation.referenceSchnekenberg L, 2023, J CARDIOVASC DEV DIS, V10, DOI 10.3390/jcdd10070297eng
hcfmusp.relation.referenceSchwabenland M, 2021, IMMUNITY, V54, P1594, DOI 10.1016/j.immuni.2021.06.002eng
hcfmusp.relation.referenceShah Bhushan, 2022, Indian Pacing Electrophysiol J, V22, P70, DOI 10.1016/j.ipej.2022.01.004eng
hcfmusp.relation.referenceShanks J, 2022, BASIC RES CARDIOL, V117, DOI 10.1007/s00395-022-00911-0eng
hcfmusp.relation.referenceShouman K, 2021, CLIN AUTON RES, V31, P385, DOI 10.1007/s10286-021-00803-8eng
hcfmusp.relation.referenceSisó-Almirall A, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18084350eng
hcfmusp.relation.referenceSotak Stefan, 2022, Vnitr Lek, V68, P11, DOI 10.36290/vnl.2022.100eng
hcfmusp.relation.referenceStefanou MI, 2022, THER ADV CHRONIC DIS, V13, DOI 10.1177/20406223221076890eng
hcfmusp.relation.referenceStute NL, 2021, J PHYSIOL-LONDON, V599, P4269, DOI 10.1113/JP281888eng
hcfmusp.relation.referenceSuh HW, 2023, HEALTHCARE-BASEL, V11, DOI 10.3390/healthcare11081095eng
hcfmusp.relation.referenceSzabo S, 2023, INFLAMMOPHARMACOLOGY, V31, P551, DOI 10.1007/s10787-023-01194-0eng
hcfmusp.relation.referenceTanmay S, 2021, FOOD CHEM TOXICOL, V152, DOI 10.1016/j.fct.2021.112184eng
hcfmusp.relation.referenceTaquet M, 2022, LANCET PSYCHIAT, V9, P815, DOI 10.1016/S2215-0366(22)00260-7eng
hcfmusp.relation.referenceThayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543eng
hcfmusp.relation.referenceTheoharides TC, 2022, MOL NEUROBIOL, V59, P1850, DOI 10.1007/s12035-021-02696-0eng
hcfmusp.relation.referenceTillman TS, 2023, ACS CHEM NEUROSCI, DOI 10.1021/acschemneuro.2c00610eng
hcfmusp.relation.referenceVanderheiden A, 2022, CURR OPIN NEUROBIOL, V76, DOI 10.1016/j.conb.2022.102608eng
hcfmusp.relation.referenceVondrasek JD, 2022, HEALTHCARE-BASEL, V10, DOI 10.3390/healthcare10122465eng
hcfmusp.relation.referenceWegeberg AML, 2020, MEDIAT INFLAMM, V2020, DOI 10.1155/2020/3590389eng
hcfmusp.relation.referenceWilliams DP, 2019, BRAIN BEHAV IMMUN, V80, P219, DOI 10.1016/j.bbi.2019.03.009eng
hcfmusp.relation.referenceYang Z, 2018, EPILEPSY RES, V146, P151, DOI 10.1016/j.eplepsyres.2018.08.002eng
hcfmusp.relation.referenceZadeh Farigol Hakem, 2023, Arch Microbiol Immunol, V7, P36eng
hcfmusp.relation.referenceZanin A, 2023, SCI REP-UK, V13, DOI 10.1038/s41598-023-35086-8eng
hcfmusp.relation.referenceZhu ZC, 2021, IMMUN INFLAMM DIS, V9, P1071, DOI 10.1002/iid3.471eng
hcfmusp.scopus.lastupdate2024-05-17
relation.isAuthorOfPublicationf0d8191d-c9e4-4871-b4fa-f6fc871ef693
relation.isAuthorOfPublication21c600cf-65b7-470b-86b5-b026e90ff13a
relation.isAuthorOfPublication.latestForDiscoveryf0d8191d-c9e4-4871-b4fa-f6fc871ef693
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
art_MARQUES_Cardiovascular_autonomic_dysfunction_in_Long_COVID_pathophysiology_heart_2023.PDF
Tamanho:
4.01 MB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)